ReviewFrontiers in oncology2020
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells.
Wen-Qi Cai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
116 papers cite itlatest 60 shown
this paperpooled itcites it